Most Recent
Judge mulls contradictor in $105M Boston Scientific class action settlement despite no red flags
The judge overseeing a class action against US medical device maker Boston Scientific is considering appointing a contradictor to look over the $105 million settlement reached in the case, despite seeing no obvious obstacle to approving the deal.
Pelvic mesh class action halted after Astora files for bankruptcy in US
A judge has paused a class action on behalf of 6,000 women allegedly injured by defective pelvic mesh devices pending determination of an application by Astora Health for a stay of the proceedings following its bankruptcy filing.
Criminal case should run before COVID-19 hotel quarantine class action, court told
The state of Victoria has brought criminal action against the DHHS over its handling of the hotel quarantine debacle in 2020 and wants to push off separate class action proceedings until the charges are heard.
Pelvic mesh victim who opted out of class action can sue bankrupt Astora
A woman allegedly injured by a defective pelvic mesh product has won her bid to bring a lawsuit against bankrupt Astora Women's Health after she opted out of a class action, which promised her no more than $10,000 under a proposed settlement.
Essure class action slams Bayer’s bid for applicant’s teen medical records
The lead applicant in a class action against Bayer over its Essure contraceptive device has admonished the drug maker’s request for her medical records since the age of 14, saying it had “no basis” and was a “fishing exercise”.
Government to face class action over NDIS age exclusion
The federal government will face a class action on behalf of disabled individuals age 65 and over who have been excluded from the National Disability Insurance Scheme.
Mylan appeals ATO’s rejection of $48M deduction in spat over $1.2B Alphapharm deal
The Australian unit of Mylan is challenging the ATO's rejection of a $48 million deduction  for 2020 in the generic drug company's latest spat with the tax office over interest on loans to fund its $1.2 billion acquisition of generic drug maker Alphapharm.
Fresenius Kabi, Samsung Bioepis lock horns again over Humira biosimilar
German biotech Fresenius Kabi has struck back at Samsung Bioepis's latest attack on the validity of its patents for a liquid formulation of top selling immunosuppressant drug Humira, accusing the Korean company of causing its sales to flag by infringing the patent.
J&J, Ethicon to pay record $300M settlement in pelvic mesh class actions
Johnson & Johnson Medical and unit Ethicon have agreed to pay $300 million to settle two class actions brought by Shine Lawyers on behalf of Australian women implanted with pelvic mesh and tape devices.
Apple hit with suit over App Store takedown
Apple has been sued by a microneedling pen company that alleges it suffered loss when the tech giant removing its app from the App Store based on bogus claims of trade mark infringement.